Sector Update: Healthcare

By
A A A

Healthcare shares are flat to higher in pre-market trade.

Shares of Rosetta Genomics ( ROSG ) are up 35% at $4.29 pre-market after the company said it has signed a master service provider agreement with an undisclosed "major global biopharmaceutical company," under which Rosetta will provide its microRNA profiling and other services pursuant to a collaboration in important areas of unmet medical need utilizing a novel therapeutic approach.

And, Biopharmaceutical company Cubist Pharmaceuticals ( CBST ) reported that its total net revenues for Q4 were $299.7 million, including DIFICID revenues since the completion of CBST's acquisition of Optimer Pharmaceuticals, Inc. on Oct. 24, 2013. This is up 22% compared to $245.9 million in Q4 2012. Analysts are expecting Q4 revenues of $280.82 million, if comparable.

For FY13, the company expects to report net revenues of $1.1 billion, up 14% compared to $926.4 million in 2012. Analysts are looking for revenues of $1.03 billion.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: CBST , ROSG

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

67,310,517
  • $100.53 ▲ 1.38%
50,893,843
  • $8.02 ▲ 2.56%
48,783,882
  • $10.25 ▲ 3.85%
43,859,280
  • $5.39 ▼ 4.09%
41,392,452
    $15.45 unch
31,440,620
  • $8.09 ▲ 3.45%
30,705,588
  • $3.11 ▲ 0.97%
28,829,509
  • $3.87 ▲ 19.44%
As of 8/19/2014, 04:03 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com